Concerns about the approval of lecanemab for Alzheimer's disease
- PMID: 40262845
- DOI: 10.1136/bmj.r778
Concerns about the approval of lecanemab for Alzheimer's disease
Conflict of interest statement
Competing interests: None of the authors reports a conflict of interest. SB, CC, LM, FN, ER, and PW are core members of the independent Scientific Advisory Group (SAG) Neurology at the European Medicines Agency. EE and SEJ are patient representatives and members of SAG Neurology. DR and FJW are members of SAG Neurology. No specific funding was obtained for this letter. ER drafted the manuscript and all authors commented on the draft version. All authors approved the final version.
Publication types
LinkOut - more resources
Full Text Sources